PT  - JOURNAL ARTICLE
AU  - Zakharia, Yousef
AU  - McWilliams, Robert R
AU  - Rixe, Olivier
AU  - Drabick, Joseph
AU  - Shaheen, Montaser F
AU  - Grossmann, Kenneth F
AU  - Kolhe, Ravindra
AU  - Pacholczyk, Rafal
AU  - Sadek, Ramses
AU  - Tennant, Lucinda L
AU  - Smith, Christopher M
AU  - Kennedy, Eugene P
AU  - Link Jr, Charles J
AU  - Vahanian, Nicholas N
AU  - Yu, Jiayi
AU  - Shen, Steven S
AU  - Brincks, Erik L
AU  - Rossi, Gabriela R
AU  - Munn, David
AU  - Milhem, Mohammed
TI  - Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma
AID  - 10.1136/jitc-2020-002057
DP  - 2021 Jun 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e002057
VI  - 9
IP  - 6
4099  - http://jitc.bmj.com/content/9/6/e002057.short
4100  - http://jitc.bmj.com/content/9/6/e002057.full
SO  - J Immunother Cancer2021 Jun 01; 9
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.